Regulus Therapeutics (RGLS) Tops Q4 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. TFII
6. LYB
7. LITE
8. NVT
9. SPY
10. AAPL

Go back to Regulus Therapeutics (RGLS) Tops Q4 EPS by 11c

Regulus Reports Fourth Quarter and Year-End 2015 Financial Results and Recent Highlights

February 22, 2016 4:05 PM EST

LA JOLLA, Calif., Feb. 22, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights. 

"2015 was a milestone year for the company with the filing of three investigational new drug applications in the United States, and two clinical trial applications in the European Union,"... More